Skip to content
Drug recall · FDA · Published November 11, 2020

Teva Pharmaceuticals USA recalls Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose

Teva Pharmaceuticals USA recalls Testosterone Gel 1% (2.5g units) due to high drug concentration in stability testing. This may cause unsafe levels of testosterone. Contact for details.

🇺🇸 FDA recall #D-0100-2021DrugTeva Pharmaceuticals USA ›
Take action

Contact the company & request your remedy

Recalling firmTeva Pharmaceuticals USA400 Interpace Pkwy, N/A · Parsippany, NJ 07054-1120
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Teva Pharmaceuticals USA is recalling Testosterone Gel 1% products that may have higher-than-stated testosterone levels. This could lead to unsafe hormone exposure if used as directed. Read more at govinfonow.com/recall/36685-teva-testosterone-gel-1-recall-high-drug-concentration-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/36685-teva-testosterone-gel-1-recall-high-drug-concentration-risk · Updated October 4, 2026 · FDA enforcement record: FDA #D-0100-2021

Cite this page

“Teva Testosterone Gel 1% Recall: High Drug Concentration Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36685-teva-testosterone-gel-1-recall-high-drug-concentration-risk. Based on FDA recall #D-0100-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0100-2021%22&limit=1).

Why it’s dangerous

The gel may contain higher-than-stated testosterone levels due to stability testing issues. This could lead to unsafe hormone exposure if used as directed.

Who’s affected

People who have received this testosterone gel for medical treatment. Those with hormone-sensitive conditions may be at higher risk.

How to tell if you have this one

Look for Testosterone Gel 1% products with 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17). These were sold in cartons with NDC 0591-3216-30, manufactured by Actavis Laboratories UT, Inc.

  • Brand
    Teva Pharmaceuticals USA
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product label for NDC 0591-3216-17 and 30 Unit-Dose Packets per carton.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is due to potential higher-than-stated testosterone levels, but the product is still safe for medical use under supervision.

How do I know if I have the recalled product?

Look for Testosterone Gel 1% with NDC 0591-3216-17 in 2.5 gram Unit-Dose Packets (30 per carton).

What should I do if I have this product?

Check the product details to confirm; if recalled, contact Teva Pharmaceuticals USA for guidance.

Take action

Contact Teva Pharmaceuticals USA

We’ve drafted a message you can send Teva Pharmaceuticals USA to request your refund or repair — edit it as you like.

Subject: Recall D-0100-2021 — Teva Pharmaceuticals USA Teva Pharmaceuticals USA

Hello,

I own a Teva Pharmaceuticals USA that is covered by recall D-0100-2021 from Teva Pharmaceuticals USA.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0100-2021 (November 11, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0100-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA